Nancy E. Messonnier, MD is Director of the National Center for Immunization and Respiratory Diseases (NCIRD) at the @CDC and leads the CDC’s efforts on COVID-19 vaccination. She joins JAMA's Q&A series to discuss the agency's response to emerging coronavirus variants, the FDA advisory hearings on the new @jnj vaccine, and other agency activities and priorities related to COVID-19 control. Recorded February 26, 2021.
Topics discussed in this interview:
0:00 Introduction
0:36 Variants
2:55 Rapidity of variant emergence
3:55 Staying the course with vaccination
5:52 Speed of vaccine deployment
7:05 Supply of vaccines
8:01 Struggles with distribution
9:20 Incentives for vaccination
12:05 Delaying the second dose
13:44 Vaccination with prior infection
14:52 Stratifying vaccines for different groups
18:09 Vaccination during pregnancy and breastfeeding
20:14 Immunocompromised individuals
22:38 Duration of immunity
23:50 Safety surveillance systems
26:46 Global approach to vaccination
28:28 AstraZeneca and Novavax
29:10 Surprises
30:59 Speed of vaccine development
32:21 Livestream interruption
35:17 Livestream continues
36:23 Booster doses
36:45 Which vaccine the Queen of England got
37:25 Equity and vaccine distribution
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at [ Ссылка ]
• Coronavirus Resource page from the JAMA Network: [ Ссылка ]
• To watch all the #JAMALive Q&A's Visit: [ Ссылка ]
• Don't forget to hit subscribe or click [ Ссылка ]
---------------------------------------------------------------------------------
For more from JAMA
• [ Ссылка ]
• [ Ссылка ]
• [ Ссылка ]
• [ Ссылка ]
Follow the JAMA Network
• [ Ссылка ]
• [ Ссылка ]
• [ Ссылка ]
• [ Ссылка ]
• [ Ссылка ]
• [ Ссылка ]
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
